deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT01996449

The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension

Sponsor: University of Texas Southwestern Medical Center

Conditions Hypertension
Updated 14 times since 2017 Last updated: Feb 22, 2022 Started: Jul 31, 2013 Primary completion: Apr 30, 2021 Completion: Apr 30, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Hypertension and is currently completed. University of Texas Southwestern Medical Center leads this study, which shows 14 recorded versions since 2013 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshot~Feb 2019 – ~Apr 2020 · 14 months · monthly snapshot~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Feb 2022 · 10 months · monthly snapshot~Feb 2022 – ~Mar 2022 · 28 days · monthly snapshot~Mar 2022 – ~Apr 2022 · 31 days · monthly snapshot~Apr 2022 – ~Dec 2022 · 8 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

14 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2

  5. Apr 2022 — Dec 2022 [monthly]

    Completed PHASE2

Show 9 earlier versions
  1. Mar 2022 — Apr 2022 [monthly]

    Completed PHASE2

  2. Feb 2022 — Mar 2022 [monthly]

    Completed PHASE2

    Status: RecruitingCompleted · Phase: NAPHASE2

  3. Apr 2021 — Feb 2022 [monthly]

    Recruiting NA

  4. Jan 2021 — Apr 2021 [monthly]

    Recruiting NA

  5. Apr 2020 — Jan 2021 [monthly]

    Recruiting NA

  6. Feb 2019 — Apr 2020 [monthly]

    Recruiting NA

  7. Jun 2018 — Feb 2019 [monthly]

    Recruiting NA

  8. Feb 2017 — Jun 2018 [monthly]

    Recruiting NA

  9. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Texas Southwestern Medical Center
Data source: University of Texas Southwestern Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations